Literature DB >> 8259214

p21 is a universal inhibitor of cyclin kinases.

Y Xiong1, G J Hannon, H Zhang, D Casso, R Kobayashi, D Beach.   

Abstract

Deregulation of cell proliferation is a hallmark of neoplastic transformation. Alteration in growth control pathways must translate into changes in the cell-cycle regulatory machinery, but the mechanism by which this occurs is largely unknown. Compared with normal human fibroblasts, cells transformed with a variety of viral oncoproteins show striking changes in the subunit composition of the cyclin-dependent kinases (CDKs). In normal cells, CDKs exist predominantly in multiple quaternary complexes, each containing a CDK, cyclin, proliferating cell nuclear antigen and the p21 protein. However, in many transformed cells, proliferating cell nuclear antigen and p21 are lost from these multiprotein enzymes. Here we have investigated the significance of this phenomenon by molecular cloning of p21 and in vitro reconstitution of the quaternary cell-cycle kinase complexes. We find that p21 inhibits the activity of each member of the cyclin/CDK family. Furthermore, overexpression of p21 inhibits the proliferation of mammalian cells. Our results indicate that p21 may be a universal inhibitor of cyclin kinases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8259214     DOI: 10.1038/366701a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  847 in total

Review 1.  Functional role of p21 during the cellular response to stress.

Authors:  M Gorospe; X Wang; N J Holbrook
Journal:  Gene Expr       Date:  1999

2.  Identification of genes highly expressed in G2-arrested Chinese hamster ovary cells by differential display analysis.

Authors:  Y Sasaki; F Itoh; H Suzuki; T Kobayashi; H Kakiuchi; M Hareyama; K Imai
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

3.  Extracellular matrix modulates enterocyte growth via downregulation of c-jun but is independent of p21 and p27 expression.

Authors:  S I Wolpert; K M Lally; J Li; J Y Wang; B L Bass
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

4.  Middle T antigen activation of signal transduction pathways does not overcome p53-mediated growth arrest.

Authors:  J Doherty; R Freund
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  The G(2) checkpoint is maintained by redundant pathways.

Authors:  T M Passalaris; J A Benanti; L Gewin; T Kiyono; D A Galloway
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

6.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.

Authors:  R Zhao; K Gish; M Murphy; Y Yin; D Notterman; W H Hoffman; E Tom; D H Mack; A J Levine
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

Review 7.  Demystified ... p53.

Authors:  S J Darnton
Journal:  Mol Pathol       Date:  1998-10

8.  Tumor extension and cell proliferation in adenocarcinomas of the lung.

Authors:  M Shoji; Y Dobashi; S Morinaga; S X Jiang; T Kameya
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

9.  MDM2 suppresses p73 function without promoting p73 degradation.

Authors:  X Zeng; L Chen; C A Jost; R Maya; D Keller; X Wang; W G Kaelin; M Oren; J Chen; H Lu
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

10.  The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest.

Authors:  J R Yeh; R Mohan; C M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.